EpiVax will be joining more than 1,400 companies from over 45 countries at Bio-Euro
pe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Partner with us to hear about our new immunoinformatics platform accelerating the advancement of personalized cancer vaccine design.
Bio-Europe Spring
